Amber Lifesciences Metformin Sitagliptin

Amber lifescience supplies high quality of combination tablets containing metformin and sitagliptin are available in different strengths. The main purpose of this drug is to treat type 2 diabetes. Sitagliptin boosts insulin secretion by inhibiting DPP-4 enzymes, whereas metformin decreases hepatic glucose synthesis and improves insulin sensitivity. The availability of strength includes Metformin 500-1000 mg and Sitagliptin 25-50 mg are usually taken twice day as per consulting physician recommendations.